Is there a relation between urinary interleukin-6 levels and symptoms before and after intra-vesical glycosaminoglycan substitution therapy in patients with bladder pain syndrome/interstitial cystitis?

International Urogynecology Journal

Volumn 18, Issue 12, 2007, Pages 1449-1452

  Daha, Lukas K ^a   Lazar, Dara ^a   Simak, Reiner ^a   Pflüger, Heinz ^a  

^a LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

Author keywords

Bladder; Hyaluronic acid; Interleukin; Interstitial cystitis; Pentosanpolysulphate

Indexed keywords

BIOLOGICAL MARKER; GLYCOSAMINOGLYCAN; HYALURONIC ACID; INTERLEUKIN 6; PENTOSAN POLYSULFATE;

ADULT; ANALYTIC METHOD; ARTICLE; CLINICAL ARTICLE; CORRELATION ANALYSIS; CYSTALGIA; DISEASE SEVERITY; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FEMALE; HUMAN; IMMUNOASSAY; INTERSTITIAL CYSTITIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; QUALITY OF LIFE; QUANTITATIVE ANALYSIS; SCORING SYSTEM; SUBSTITUTION THERAPY; SYMPTOM; TREATMENT DURATION; TREATMENT RESPONSE; URINALYSIS; VISUAL ANALOG SCALE;

EID: 35948951211     PISSN: 09373462     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00192-007-0354-4     Document Type: Article

References (20)

1. Hanno PM (2005) Painful bladder syndrome/interstitial cystitis and related disorders. In: Patrick C, Walsh PC, Retik AB, Vaughan ED Jr, Wein AJ (eds) Campbell's urology, 8th edn. Saunders, Philadelphia, p 631
2. Lotz M, Villiger P, Hugli T, Koziol J, Zuraw BL (1994) Interleukin-6 and interstitial cystitis. J Urol 152(3):869-873
3. Erickson DR, Xie SX, Bhavanandan VP, Wheeler MA, Hrust RE, Demers LM, Kushner L, Keay SK (2002) A comparison of multiple urinary markers for interstitial cystitis. J Urol 167:2461-2469
4. Felsen D, Frye S, Trimble LA, Bavendam TG, Parsons CL, Sim Y, Vaughan ED Jr (1994) Inflammatory mediator profile in urinary and bladder wash fluid of patients with interstitial cystitis. J Urol 152:355-361
5. Seguchi T, Yokokawa K, Sugao H, Nakano E, Sonoda T, Okuyama A (1992) Interleukin-6 activity in urine and serum in patients with bladder carcinoma. J Urol 148:791
6. Davidoff R, Yamaguchi R, Leach GE, Park E, Lad PM (1997) Multiple urinary cytokines levels of bacterial cystitis. J Urol 157:1980-1985
7. Bouchelouche K, Alvarez S, Horn T, Nordling J, Bouchelouche P (2006) Human detrusor smooth muscle cells release interleukin-6, interleukin-8, and RANTES in response to proinflammatory cytokines interleukin-1β and tumor necrosis factor-α. Urology 67 (1):214-219
8. Lotz M (1993) Interleukin-6. Cancer Invest 11:732-742
9. Erickson DR, Belchis DA, Dabbs DJ (1997) Inflammatory cell types and clinical features of interstitial cystitis. J Urol 158:790
10. Peters KM, Diokno AC, Steinert BW (1999) Preliminary study on urinary cytokine levels in interstitial cystitis: Does intravesical Bacille Calmette-Guèrin treat interstitial cystitis by altering the immune profile in the bladder? Urology 54:450-453
11. Leppilahti M, Hellström P, Tammela TL (2002) Effect of diagnostic hydrodistension and four intravesical hyaluronic acid instillations on bladder ICAM-1 intensity and association of ICAM-1 intensity with clinical response in patients with interstitial cystitis. Urology 60:46-51
12. Gillenwater JY, Wein AJ (1988) Summary of the National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases Workshop on Interstitial Cystitis, National Institutes of Health, Bethesda, Maryland, August 28-29, 1987. J Urol 140:203-206
13. Daha LK, Riedl CR, Hohlbrugger G, Knoll M, Engelhardt PF, Pflüger H (2003) Comparative assessment of maximal bladder capacity, 0.9% NaCl versus 0.2 M KCl, for the diagnosis of interstitial cystitis: A prospective controlled study. J Urol 170:807-809
14. O'Leary MP, Sant GR, Fowler FJ Jr, Whitmore KE, Spolarich-Kroll J (1997) The interstitial cystitis symptom index and problem index. Urology 49(5A Suppl):58-63
15. Hurst RE, Zebrowski R (1994) Identification of proteoglycans present at high density on bovine and human bladder luminal surface. J Urol 152:1641-1644
16. Hurst RE (1994) Structure, function, and pathology of proteoglycans and glycosaminoglycans in the urinary tract. World J Urol 12:3-10
17. Bade JJ, Laseur M, Nieuwenburg A, van der Weele LT, Mensink HJ (1997) A placebo-controlled study of intravesical pentosanpolysulphate for the treatment of interstitial cystitis. Br J Urol 79:168-171
18. Riedl CR, Daha LK, Pflüger H, Hohlbrugger G (2004) Intravesical hyaluronic acid for the treatment of interstitial cystitis: An update. European Association of Urology (EAU) Congress (Supp 3), Vienna, Austria, March 2004
19. Morales A, Emerson L, Nickel JC, Lundie M (1996) Intravesical hyaluronic acid in the treatment of refractory interstitial cystitis. J Urol 156:45-48
20. Porru D, Campus G, Tudino D, Valdes E, Vespa A, Scarpa RM, Usai E (1997) Results of treatment of refractory interstitial cystitis with intravesical hyaluronic acid. Urol Int 59:26-29